Oct 2026
Anakinra for the Treatment of Severe Still's Disease Complicated With Macrophage Activation Syndrome
To investigate the efficacy and safety of add‐on anakinra for severe Still's disease complicated by macrophage activation syndrome (MAS) in a real‐world setting.
Jia-Xian Guo, Hao-Jie Xu, Wei-Wei Li et al.
· International Journal of Rhe... · 0 citations